Newsroom

DUBLIN--(BUSINESS WIRE)--The "AI-Powered Fleet-Management Software - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for AI-Powered Fleet-Management Software was valued at US$5.2 Billion in 2024 and is projected to reach US$14.4 Billion by 2030, growing at a CAGR of 18.7% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The gr...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 426,390 shares originally issued in February 2025 and September 2025, having exercise prices of $36.00 and $10.98...

LYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic dysfunction-associated steatohepatitis (MASH) and rare metabolic disorders, today announces that it held its Combined General Meeting on Thursday, December 11, 2025, at 10:00 am CET at the Mercure Lyon Centre Château Perrache Hotel, located at 12 Cour...

LYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), société biopharmaceutique au stade clinique développant des traitements innovants pour les maladies chroniques graves à physiopathologie métabolique, dont la stéatohépatite associée à un dysfonctionnement métabolique (MASH) et les maladies métaboliques rares, informe ses actionnaires que son Assemblée Générale Mixte s’est tenue le jeudi 11 décembre 2025 à 10h00 à l’Hôtel Mercure Lyon Centre Château Perra...

DUBLIN--(BUSINESS WIRE)--The "Acute Hospital Care Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The global acute hospital care market is adapting to rapid regulatory, operational, and technological changes, compelling healthcare leaders to reassess pathways for growth, resilience, and strategic investment. Market Snapshot: Acute Hospital Care Market Size and Growth Outlook The acute hospital care market rose from USD 3.45 trillion in 2024 to USD...

NEW YORK--(BUSINESS WIRE)--Integer Holdings Corporation Lowered Sales Outlook Triggers Securities Fraud Class Action after Stock Drops Over 32% -- Investors Urged to Contact BFA...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Alexander & Baldwin, Inc. (NYSE: ALEX) to MW Group and funds affiliated with Blackstone Real Estate and DivcoWest. Under the terms of the proposed transaction, shareholders of Alexander will receive $21.20 in cash for each share of Alexander that they own. KSF is seeking to determine whether thi...

NEW YORK--(BUSINESS WIRE)--Pangram 3.0 released. Pinpoints text that has been created, revised, or edited with AI-powered tools....

DALLAS--(BUSINESS WIRE)--Dickey’s Barbecue Pit is turning up the holiday cheer with the official launch of the 12 Days of Pitmas, a festive, fan-favorite celebration packed with free food, big prizes, and more than 60 chances to win. Beginning December 13, fans across the country can join the fun by following the brand’s official Instagram page at @dickeysbarbecuepit for daily giveaways that brighten bellies and bring smiles all season long. The 12 Days of Pitmas has become one of Dickey’s most...

DUBLIN--(BUSINESS WIRE)--The "Neoantigen Cancer Vaccine Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The neoantigen cancer vaccine market is rapidly redefining standards in immuno-oncology by enabling patient-specific treatments that enhance therapy precision and minimize systemic side effects for oncology stakeholders. Market Snapshot: Neoantigen Cancer Vaccine Market The Neoantigen Cancer Vaccine Market grew from USD 378.66 million in 2024 to...